Common Childhood Illnesses Questions

You often can't tell for sure without a doctor. Viral illnesses (colds, most sore throats, stomach bugs) tend to come with runny nose, cough, mild fever, and get better in 5-7 days. Bacterial infections often have higher fever, are more localised (ear pain, painful urination, one-sided sore throat), and don't improve on their own. Antibiotics only help bacterial infections — using them for viruses does harm.

Dengue, typhoid, diarrhoeal illness with dehydration, and — in unvaccinated children — measles, whooping cough, and diphtheria. Also watch for tuberculosis in children who've had close contact with an adult with active TB. Routine immunisation prevents most of the vaccine-preventable diseases; hydration and hygiene help with the rest.

Watch for signs of dehydration: fewer wet nappies, dry mouth, no tears when crying, sunken eyes, unusual sleepiness, or a soft spot on the head that looks sunken in babies. Blood in stool, high fever, or diarrhoea lasting more than a week also needs a doctor. ORS (oral rehydration solution) is the mainstay — anti-diarrhoea medicines shouldn't be given to young children without medical advice.

No — and doing so is one of the biggest drivers of antibiotic resistance in India. Most coughs and colds are viral and antibiotics won't help. A good doctor won't prescribe antibiotics reflexively; if one does, it's fair to ask why. Save antibiotics for when they're genuinely needed — otherwise they lose power against future infections.

Handwashing before eating and after using the toilet is the single biggest lever. Beyond that: keep vaccinations current, teach cough etiquette (into the elbow, not hands), avoid sharing water bottles or tiffins, and keep them home when actually sick (fever, diarrhoea, vomiting) so they don't spread it. Some illness is unavoidable — it's part of how a child's immune system develops.

7 to 8 hour sleep is essential.

Under India's Universal Immunization Programme (UIP), PCV is given at 6 weeks, 14 weeks, and 9 months (a 2p+1 schedule using PCV13). In private paediatric practice, the older 2+1+booster schedule is common: doses at 6, 10, and 14 weeks with a booster at 12-15 months. Missing a dose isn't a disaster — the paediatrician can adjust the catch-up schedule. PCV was added to India's national programme in phases starting 2017 and is now available free across all states.

Adult dementia (Alzheimer's, vascular) is a disease of the aging brain — the brain developed normally and then degenerated. Childhood dementia interrupts brain development itself, usually before age 10, from a genetic or metabolic root cause. Adult dementia typically progresses over years; childhood dementia often progresses over months once symptoms start. The vocabulary overlaps (memory loss, cognitive decline, seizures) but the underlying disease process is completely different, which is why the two conditions need different specialists — pediatric neurology and geneticists for children, not the adult-dementia care pathway.

PCV13 (Prevnar 13 by Pfizer, Pneumosil by Serum Institute) protects against 13 pneumococcal serotypes; PCV10 (Synflorix by GSK, Pneumosil by Serum India) covers 10. India's UIP switched to PCV13 nationwide (Pneumosil), giving broader coverage against Indian-prevalent serotypes. PCV13 costs ₹3,800-5,500 per dose in private hospitals; free under UIP at government centres. Both are equally safe — the extra 3 serotypes in PCV13 protect against strains still common in South Asia.

Very safe — one of the most-studied childhood vaccines globally, with 20+ years of data. Common mild side effects (in 30-50% of infants) include redness or swelling at the injection site, low-grade fever, sleepiness, and reduced appetite for 24-48 hours. Give paracetamol drops per your paediatrician's advice if fever crosses 100.4°F (38°C). Serious reactions are extremely rare. The benefit — protection against invasive pneumococcal disease which killed an estimated 105,000 Indian children under 5 in the pre-PCV era — massively outweighs the mild transient discomfort.

No — PCV is separate and additional. It's given alongside Hib (Haemophilus influenzae b), rotavirus, pentavalent (DPT + HepB + Hib), IPV/OPV (polio), and later MMR — all at overlapping visits. PCV protects against Streptococcus pneumoniae; Hib protects against a different bacterium that also causes meningitis. Both are needed. Your paediatrician's vaccination card lists everything due at each visit — bring it to every appointment.

Most types have no cure yet, but three matter: (1) a few conditions have disease-modifying treatments — miglustat for Niemann-Pick C, cerliponase alfa (Brineura) for CLN2 Batten disease, enzyme replacement therapy for some MPS conditions — best started early. (2) Symptomatic care from a multidisciplinary team (pediatric neurologist, physiotherapist, speech therapist, special educator) preserves function for longer. (3) Palliative care and family support are essential because most conditions shorten life. In India, AIIMS, NIMHANS, and CMC Vellore run pediatric neurogenetics clinics equipped for this workup.

Most cases are genetic. About 70 identified conditions cause childhood dementia, and nearly all are single-gene disorders passed down when both parents carry a recessive mutation. The most common are Batten disease (CLN gene family), Niemann-Pick disease type C, Sanfilippo syndrome (MPS-III), and Rett syndrome. Non-genetic causes are rare — severe untreated infections, traumatic brain injury, or lead poisoning. If one child is diagnosed, siblings and future pregnancies should have genetic counselling and testing.

Loss of already-acquired skills is the hallmark red flag — a toddler who could walk starts falling, a child who could speak in sentences loses vocabulary, or a child who was toilet-trained regresses. Other early signs include unexplained seizures, gradual vision loss, motor coordination problems, and behavioural changes. Because these conditions are rare (roughly 1 in 2,900 children globally per Batten Disease Support Network estimates), pediatricians may take months to reach a diagnosis — insist on referral to a pediatric neurologist if skill regression persists beyond 3-6 months.

Yes, virtual speech therapy sessions with certified therapists are highly effective and offer additional guidance for parents and caregivers.

Flashcards, speech therapy apps, reading exercises, and mirror techniques can aid in speech improvement at home.

Parents can assist with therapy by using recommended techniques, but professional guidance from a speech therapist is crucial for effective progress.

The duration varies depending on the individual's needs. Some may see improvement within a few months, while others require ongoing therapy for years.

Seek urgent care for difficulty breathing, chest pain, bluish lips/face, new confusion, severe weakness, severe dehydration, persistent vomiting, severe abdominal pain, seizures, new bleeding, or blood in vomit or stool. For suspected dengue, watch for severe abdominal pain, persistent vomiting, rapid breathing, bleeding gums, or extreme weakness.

Antibiotics are only effective against bacterial infections. They do not treat viral infections like the flu, COVID-19, or dengue. Taking antibiotics unnecessarily can lead to antibiotic resistance and side effects.

While many viral infections improve on their own, persistent fever and cough for three days warrant attention, especially if symptoms are not improving, are staying the same, or are worsening. Seek medical evaluation if you experience increasing breathlessness, chest pain, confusion, or severe weakness.

It is often not possible to distinguish between COVID-19 and the flu based solely on symptoms like fever, cough, and body aches, as they overlap significantly. Testing is usually required to confirm a diagnosis for either illness.

Flu commonly causes fever, cough, body aches, and fatigue with a sudden onset. Dengue fever typically presents with high fever, severe headache, pain behind the eyes, muscle/joint pain, nausea, and sometimes a rash, but a prominent cough is not a typical symptom. Dengue also carries a risk of bleeding and severe abdominal pain as warning signs.

Yes, for some people, a chronic cough can be the main or only symptom of asthma. This cough might worsen at night, with exercise, or due to cold air or allergens.

You should see a doctor if your cough has lasted over a few weeks and isn't improving, is getting worse, repeatedly returns, or interferes with sleep or daily activities. Seek immediate medical care for difficulty breathing, coughing up blood, severe chest pain, confusion, or blue/grey skin.

Common causes of chronic cough include post-infectious airway irritation, asthma, allergies leading to postnasal drip, acid reflux (even without heartburn), smoking, exposure to irritants, and side effects from certain medications like ACE inhibitors.

A cough can linger for several weeks after a respiratory infection due to irritated airways. While acute coughs last less than 3 weeks, subacute coughs can persist for 3-8 weeks. If a cough lasts longer than 8 weeks, it's considered chronic and may require medical evaluation.

Latent TB means the M. tuberculosis bacteria are in your body but contained by your immune system inside granulomas, you have no symptoms, are not infectious, and cannot spread the disease. Chest X-ray is usually normal; TB is detected only through Mantoux test or IGRA blood test. Active TB means the bacteria have broken out of containment and are multiplying, causing symptoms (persistent cough, weight loss, night sweats, low-grade fever) and making you infectious to others. Roughly 5-10% of people with latent TB will develop active TB at some point in their lifetime, with the risk highest in the first 2 years after exposure and in anyone whose immune system weakens (HIV, diabetes, steroids, TNF inhibitors, aging). Whether latent TB needs treatment depends on individual risk. WHO recommends preventive treatment for household contacts of active TB cases, HIV-positive people, people starting immunosuppressive drugs, and healthcare workers with recent conversion. India's NTEP is expanding preventive TB treatment access, particularly for household contacts.

Ask for a peripheral blood smear as your primary test, thick smear for detection, thin smear for species identification. A rapid diagnostic test (RDT) is a reasonable add-on, especially if you are in a smaller clinic or evening hours when a microscopist may not be available; RDT gives a result in 15-20 minutes. If both are negative but fever and symptoms persist for another 24-48 hours, a repeat smear at a good centre or a PCR test at a tertiary hospital is the next step. Do not rely on RDT alone if your clinical picture is convincing, low-parasitemia infections and non-falciparum species (P. vivax, P. ovale) can be missed by rapid tests.

In government hospitals, both RDT and blood smear are typically free or nominal. In private labs, RDT and blood smear together are usually affordable and results come back the same day. RDT within 20-30 minutes, smear within 2-4 hours if the lab has a technician on shift. PCR is only available at larger hospitals and reference laboratories; it is significantly more expensive and takes 24-72 hours depending on the batch schedule. For anyone with fever in an endemic area, testing should not be delayed by cost, a delayed diagnosis in P. falciparum malaria can escalate to cerebral malaria within days.

A negative RDT does not rule out malaria, especially in the first 24-48 hours of illness or in P. vivax infection where parasite levels can be low. Next steps: (a) request a thick and thin blood smear read by an experienced microscopist, this is more sensitive than an RDT and identifies the species; (b) if smear is also negative but fever continues past 48 hours, repeat the smear, parasitemia rises with each fever cycle and can become detectable; (c) discuss PCR testing at a tertiary centre if smears remain negative but symptoms are strongly suggestive; (d) in parallel, work up other causes of fever in India, dengue, typhoid, chikungunya, leptospirosis, urinary infection, since these can co-exist or mimic malaria.

Very urgent, especially if you have travelled to sub-Saharan Africa, the Indian North-East, Odisha, Chhattisgarh, or parts of South-East Asia where P. falciparum is common. Get tested the same day. P. falciparum malaria can progress to severe disease within 24-72 hours of first symptoms, cerebral malaria, kidney failure, severe anaemia, ARDS. Tell the doctor exactly where you travelled, when, and whether you took prophylaxis. If travel was to a P. vivax or P. ovale region, symptoms can appear weeks to months after return because these species can lie dormant in the liver, any unexplained fever within a year of travel to an endemic zone warrants a malaria test, not just antibiotics for a presumed viral illness.

Modern malaria RDTs have sensitivity of roughly 90-95% for detecting Plasmodium falciparum at typical fever-onset parasite levels, meaning they catch most cases but can miss around 5-10%. Sensitivity for P. vivax is lower, around 80-90%, because the antigens vary more across strains. Sensitivity drops significantly when parasite counts are very low (early in the illness or in asymptomatic carriers). Blood smear microscopy remains the gold standard, with sensitivity approaching 95% in expert hands and the ability to identify species and quantify parasite load. In practice, RDT is the fast first test almost anywhere in India; blood smear confirms the diagnosis and guides treatment intensity. A negative RDT with persistent malaria-suggestive symptoms should always trigger a follow-up smear rather than being taken as definitive.

Malaria RDT kits are available in India but not typically sold for home use, they are meant for clinical or field-worker settings and are usually sold to hospitals, primary health centres, NGOs, and pharmacies for point-of-care testing rather than direct-to-consumer. Even where available at retail pharmacies, home use is not recommended because: interpreting a faint test line correctly needs practice, a negative result does not rule out early-stage malaria and needs follow-up, and any positive result immediately needs a doctor visit for treatment (antimalarials are prescription-only). Practical alternative: same-day RDT plus blood smear at a diagnostic lab or general practitioner clinic is inexpensive and available in most Indian cities. Do not delay treatment while trying to diagnose at home if you have symptoms consistent with malaria after mosquito exposure.

RDTs use protein-based antibodies that degrade at high temperatures, accuracy drops meaningfully when kits are stored above 30°C for extended periods, which is a real issue in Indian summers and in rural clinics without air conditioning. Storage above 40°C can produce false negatives even for kits well within their expiry date. Practical implications: kits held in unrefrigerated pharmacy shelves during peak summer months (April-June) may perform worse than the manufacturer's stated sensitivity; kits transported without cold-chain protection in field settings often lose reliability. This is why WHO recommends RDT lot testing before deployment in endemic areas. For patients: if an RDT result seems inconsistent with your clinical picture, ask for a blood smear rather than trusting the RDT alone, the smear does not have storage-related accuracy issues.

A positive RDT confirms malaria and shifts focus immediately to two things: (a) determining severity, a doctor evaluates whether it is uncomplicated malaria (treatable at home with oral antimalarials) or severe malaria (needs hospitalisation and IV artesunate). Severe malaria indicators include altered consciousness, seizures, jaundice, dark urine, breathing difficulty, or extreme weakness. (b) identifying species, this determines the drug regimen. For P. falciparum in India, artemisinin combination therapy (ACT) is first-line; for P. vivax, chloroquine plus primaquine (primaquine treats the dormant liver stage to prevent relapse). The doctor will also order a follow-up blood smear to quantify parasite load and check response to treatment at day 3. Do not self-treat with over-the-counter antimalarials on a positive RDT, the wrong drug or dose can drive resistance and worsen outcomes.

Both P. falciparum and P. vivax are prevalent in India but they behave differently. P. falciparum is more common in Odisha, Chhattisgarh, Jharkhand, and the North-East and causes almost all severe and fatal malaria, cerebral malaria, kidney failure, ARDS, severe anaemia. It progresses fast and can kill within days if untreated. P. vivax is more widespread across the country and causes fewer deaths but has two features that matter: relapses can occur months to years after the original infection because dormant liver-stage parasites (hypnozoites) can reactivate, and chronic P. vivax weakens people over time. Any fever after being in a mosquito-endemic area should be tested regardless of which species is more common there, waiting to see if it is just viral fever can be dangerous with P. falciparum.

Because the parasite's blood-stage cycle is synchronised. All the infected red blood cells burst at roughly the same time, every 48 hours for P. vivax and P. ovale (tertian fever), 48 hours for P. falciparum (though often less regular), and 72 hours for P. malariae (quartan fever). Each mass rupture releases parasites plus toxic parasite waste products into the bloodstream, which triggers the immune system to spike fever, chills, and shivering, the classic malaria paroxysm. Between paroxysms, the parasite is quietly invading fresh red blood cells and you feel relatively normal. This cyclical pattern is so distinctive that a fever every other day in someone who has been in an endemic area should trigger a malaria test even before other symptoms develop.

The bite injects fewer than a hundred parasite sporozoites into your bloodstream, a tiny number, but they head straight for the liver within an hour. Inside a liver cell, each sporozoite multiplies silently over 7-30 days into tens of thousands of new parasites (merozoites). When the liver cell bursts, those merozoites flood into your bloodstream and start invading red blood cells. Each infected red cell then bursts every 48-72 hours, releasing more parasites, and this is when you first feel sick. So the mosquito bite is small, but the liver stage is a hidden multiplier that turns a handful of parasites into millions before symptoms even begin.

Neither. Malaria is caused by a single-celled parasite called Plasmodium, technically a protozoan, one of the oldest kinds of life on earth. Five species infect humans: P. falciparum (the most dangerous, common in Africa and parts of India's North-East and eastern states), P. vivax (the most widespread in India, causes relapsing infections), P. ovale, P. malariae, and P. knowlesi (rare, mainly South-East Asian forest exposure). Because it is a parasite and not a bacterium or virus, malaria does not respond to antibiotics or antiviral medicines. It needs specific antimalarial drugs, chloroquine, artemisinin-based combinations, or primaquine, depending on the species and drug-resistance pattern in the region.

Objective indicators of successful intervention within 24-48 hours: temperature trending down toward 37.5°C or lower without persistent antipyretic dependence; vomiting frequency reduced by at least 50%, patient tolerating small oral fluid volumes; urine output restored to at least 0.5 mL/kg/hour with clearing urine colour; heart rate and blood pressure normalising toward baseline; improving level of consciousness and patient-reported comfort. Red flags requiring escalation to the treating physician: persistent fever above 39°C beyond 48 hours of appropriate antipyretic use, worsening tachycardia despite fluid replacement, oliguria, altered mental status, new bleeding manifestations (particularly relevant in the Indian dengue season), rising creatinine, or persistent inability to tolerate oral intake. The care plan is not a static document, nursing diagnoses should be re-prioritised as the aetiology clarifies from diagnostic workup.

Establish IV access early, deteriorating patients can lose the option to hydrate orally quickly. Initiate rehydration per protocol (oral rehydration solution if tolerated; IV normal saline or Ringer's lactate if vomiting persists or dehydration is significant), correcting electrolyte deficits based on baseline labs. Administer prescribed antipyretic (paracetamol is first-line; avoid NSAIDs if dengue is on the differential due to bleeding risk) and prescribed antiemetic (ondansetron is common first-line for adults; metoclopramide alternatives). Cooling measures: tepid sponging if temperature is over 39°C, adequate exposure, ambient temperature control. Send off diagnostic samples early. CBC, electrolytes, urea/creatinine, urine routine, and pathogen-specific tests based on epidemiology (dengue NS1, malaria smear, typhoid Widal or blood culture, stool if diarrhoea present). Document baseline for evaluation.

At minimum every 4-6 hours during the acute phase: temperature (route consistent, oral, axillary, or tympanic; note the route), heart rate, blood pressure (including orthostatic if the patient is ambulant), respiratory rate, oxygen saturation, level of consciousness, and pain score. Fluid balance: strict intake and output charting, urine specific gravity or colour observation, weight if possible daily at the same time. Vomiting characterisation: frequency, volume, colour and content (bilious, coffee-ground, undigested food, blood), and relation to food or medication. Assess mucous membranes, skin turgor, and capillary refill each shift for hydration status. In endemic Indian settings, note any petechiae, rash, or bleeding, early signs of severe dengue that shift the care plan significantly.

The three anchor diagnoses in most cases: Hyperthermia related to underlying infection or inflammatory process (as evidenced by elevated body temperature above 38°C, warm skin, tachycardia); Deficient Fluid Volume or Risk for Deficient Fluid Volume related to excessive fluid loss from vomiting and insensible loss from fever (evidenced by decreased urine output, dry mucous membranes, tachycardia, hypotension); and Nausea related to gastrointestinal irritation, drug side effects, or central causes (evidenced by patient report and observed retching). Secondary diagnoses to consider based on presentation: Risk for Electrolyte Imbalance, Acute Pain (headache or abdominal), Imbalanced Nutrition Less than Body Requirements if vomiting is protracted, and Risk for Infection Transmission when the underlying cause is a communicable pathogen. Priority ordering follows Maslow, fluid balance first, then temperature, then comfort.

Most conjunctivitis treatments used in adult non-pregnant patients need re-evaluation during pregnancy. Safe in pregnancy: cold and warm compresses, preservative-free artificial tears, strict hand hygiene, and rest, the mainstays of viral conjunctivitis care. Antibiotic drops (chloramphenicol, moxifloxacin, ciprofloxacin, ofloxacin) are generally considered safe for short courses in pregnancy for bacterial conjunctivitis, but should be prescribed by an ophthalmologist rather than self-obtained. Antihistamine eye drops for allergic conjunctivitis (ketotifen, olopatadine) are considered relatively safe in pregnancy but check with your obstetrician before starting. Avoid entirely during pregnancy: steroid eye drops without ophthalmologist supervision (as always), and any oral medication for eye conditions without doctor consultation. Contact your ophthalmologist and share your pregnancy status before starting any prescription eye treatment.

Five things with real evidence for symptom relief: (1) Cold compresses, clean cloth soaked in cool water, applied to closed eyelids for 10-15 minutes, 3-4 times daily. Reduces redness, swelling, and itching. (2) Preservative-free artificial tears, flushes the surface, dilutes viral particles, reduces gritty feeling. Available at any Indian pharmacy without prescription. (3) Warm compresses in the morning to soften crusts around eyelids for gentle cleaning. (4) Strict hand hygiene, wash with soap after any eye touch, before touching food or family members. (5) Absolute avoidance of eye rubbing, contact lenses, and eye makeup for the duration. What does NOT help: honey, rose water, teabag compresses, breast milk, folk remedies popular in Indian households have no clinical evidence and can introduce further infection. What CAN worsen it: steroid drops without medical supervision, sharing towels or pillowcases with family.

Eye flu is highly contagious for 5-7 days from symptom onset, but transmission is preventable with basic hygiene. Practical measures: (a) separate personal towels, pillowcases, and face washcloths, wash the affected person's items daily in hot water. (b) Do not share eye makeup, contact lens cases, or eye drops. (c) Wash hands with soap frequently, especially after touching your eyes or face, most transmission is via hand contact. (d) Stay home from work, school, and public places while eyes are visibly red and discharging. (e) Disinfect frequently-touched surfaces daily, doorknobs, phone screens, TV remotes, taps. (f) Children should skip school for the visibly-infected period; monsoon-season school outbreaks in India spread almost entirely through shared surfaces and hand contact. Adults living in the same household have roughly a 30-50% chance of catching it despite precautions, hand hygiene matters more than any other single measure.

Getting infected and getting sick are two different things. Roughly one-third of the global population carries M. tuberculosis in latent form after some exposure, but only 5-10% ever develop active disease. Whether you progress from infection to active disease depends on multiple factors: immune status (HIV infection multiplies risk 20-30 times, diabetes doubles risk, aging weakens immunity), nutritional status (malnutrition dramatically increases risk), co-existing lung damage (smoking, silicosis, previous TB), genetic factors (specific HLA variants affect susceptibility), medications suppressing immunity (steroids, chemotherapy, TNF inhibitors), and the initial infecting dose. In India, the confluence of high HIV in some regions, high diabetes prevalence (over 100 million adults), household crowding, and undernutrition explains why India carries such a disproportionate share of the global TB burden despite decades of control efforts.

BCG (Bacillus Calmette-Guérin) vaccine has real but limited effectiveness. It reliably prevents severe childhood forms of TB. TB meningitis and disseminated (miliary) TB, with efficacy of 60-80%. It is far less effective at preventing adult pulmonary TB, with published efficacy ranging from 0% to 80% depending on the population studied, the variability itself is a major research puzzle, possibly related to prior exposure to environmental mycobacteria in different geographies. Despite this variability, India continues universal BCG vaccination at birth because the severe childhood TB prevention justifies it in a high-burden country; deaths from meningitis or miliary TB in unvaccinated Indian infants would be substantial. Improved TB vaccines are in active development globally (M72/AS01E is in phase 3 trials), but until one is approved, BCG remains standard for Indian newborns and provides genuine protection for the childhood forms that matter most in the neonatal period.

MDR-TB is TB resistant to at least isoniazid and rifampicin, the two most powerful first-line drugs. This resistance usually develops when patients receive inadequate treatment (wrong drugs, wrong doses, insufficient duration, or interruption), surviving bacteria multiply and become resistant. XDR-TB (extensively drug-resistant TB) is even more resistant, adding resistance to fluoroquinolones and injectable second-line drugs. India has among the largest number of MDR-TB cases globally. Treatment takes 9-24 months (vs 6 months for drug-sensitive TB), involves 4-7 medications simultaneously, causes more side effects, costs significantly more, and has lower cure rates (roughly 60-75% vs 85-95% for drug-sensitive TB). India's NTEP provides free MDR-TB diagnosis (GeneXpert MTB/RIF plus line probe assays) and treatment through dedicated DR-TB centres. Key patient rule: never stop TB treatment early even when feeling better, never skip doses, never take TB medications from unknown sources, creating MDR-TB harms both the patient and the community for decades.